Evidence map›Paper›PMID 41393208›Full record

ArticleRSC advances2025

β-caryolane derivatives as novel anti-colorectal cancer agents: synthesis and

Xingjun Xu, Zhiwei Wang, Anjie Huang, Zhongjing Qiao, Yonglin Ge, Hui Wen, Junxiang Cheng, Yaopeng Zhao, Xinmiao Liang

Abstract read
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xingjun XuState Key Lab of Phytochemistry and Natural Medicines, Dalian Institute of Chemical Physics, CAS Dalian 116023 China liangxm@dicp.ac.cn ypzhao@dicp.ac.cn +86-411-84379539 +86-411-84379519.ORCID https://orcid.org/0000-0003-1747-1311
Zhiwei WangState Key Lab of Phytochemistry and Natural Medicines, Dalian Institute of Chemical Physics, CAS Dalian 116023 China liangxm@dicp.ac.cn ypzhao@dicp.ac.cn +86-411-84379539 +86-411-84379519.ORCID https://orcid.org/0009-0007-0150-8219
Anjie HuangJiangxi Provincial Key Laboratory for Pharmacodynamic Material Basis of Traditional Chinese Medicine, Ganjiang Chinese Medicine Innovation Center Nanchang 330000 China.
Zhongjing QiaoJiangxi Provincial Key Laboratory for Pharmacodynamic Material Basis of Traditional Chinese Medicine, Ganjiang Chinese Medicine Innovation Center Nanchang 330000 China.
Yonglin GeJiangxi Provincial Key Laboratory for Pharmacodynamic Material Basis of Traditional Chinese Medicine, Ganjiang Chinese Medicine Innovation Center Nanchang 330000 China.
Hui WenJiangxi Provincial Key Laboratory for Pharmacodynamic Material Basis of Traditional Chinese Medicine, Ganjiang Chinese Medicine Innovation Center Nanchang 330000 China.
Junxiang ChengJiangxi Provincial Key Laboratory for Pharmacodynamic Material Basis of Traditional Chinese Medicine, Ganjiang Chinese Medicine Innovation Center Nanchang 330000 China.
Yaopeng ZhaoState Key Lab of Phytochemistry and Natural Medicines, Dalian Institute of Chemical Physics, CAS Dalian 116023 China liangxm@dicp.ac.cn ypzhao@dicp.ac.cn +86-411-84379539 +86-411-84379519.
Xinmiao LiangState Key Lab of Phytochemistry and Natural Medicines, Dalian Institute of Chemical Physics, CAS Dalian 116023 China liangxm@dicp.ac.cn ypzhao@dicp.ac.cn +86-411-84379539 +86-411-84379519.ORCID https://orcid.org/0000-0001-7542-2628

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

β-Caryolane derivatives possess a unique skeletal structure and a wide range of practical applications. Recent studies suggest that certain β-caryolane derivatives may exhibit enhanced anti-colorectal cancer activity compared to their natural parent compounds, β-caryolanol and β-caryophyllene (β-CP). However, the structural diversity of known β-caryolane derivatives remains limited, likely due to challenges in their synthesis. In this study, we systematically investigated, for the first time, the reactivity of three nucleophiles (sulfonamides, amides, and azide) with β-CP under acid catalysis. The corresponding β-caryolane-type products were successfully obtained in a single step. The azide-addition product further underwent click reactions with various alkynes to yield triazole derivatives. Compared to β-CP or β-caryolanol, most amino-substituted β-caryolane derivatives demonstrated significantly improved anti-proliferative activity against several colorectal cancer cell lines, especially HT-29 cells. Among them, compound NC-19 showed the most potent antiproliferative effect against HT-29 cells with an IC

Identifiers

PMID41393208
PMCPMC12699372

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.